Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Preparation, biological activity and use of neurokinin antagonists reported by Sanofi-Synthelabo

Jan. 13, 2000

Synsorb Cd receives fast track designation from FDA for CDAD treatment

Jan. 13, 2000

IL-1/TNF-alpha suppressant ameliorates intestinal ischemia-reperfusion injury in dogs

Jan. 13, 2000

Second pivotal phase III trial of adefovir dipivoxil as HBV treatment initiated

Jan. 12, 2000

Adult patients with chronic liver disease respond poorly to HBV vaccines

Jan. 10, 2000

BLA submitted for PEG-Intron HCV therapy

Jan. 10, 2000

Another major market launch announced for infliximab

Jan. 10, 2000

Isis and Elan to develop antisense drug for HCV

Jan. 10, 2000

Centaur continues research into potential new treatments for IBD

Jan. 10, 2000

Centaur's new NRTs and their use for treating, preventing IBD

Jan. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...